Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MGRX Mangoceuticals, Inc.

Closed 11-15 16:00:00 EST

2.31

-0.08

-3.35%

盘后2.31

+0.000.00%

19:42 EST

High2.42	Low2.27	Vol70.88K
Open2.42	D1 Closing2.39	Amplitude6.28%
Mkt Cap5.74M	Tradable Cap3.25M	Total Shares2.49M
T/O165.41K	T/O Rate5.04%	Tradable Shares1.41M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MGRX","market":"US","secType":"STK","nameCN":"Mangoceuticals, Inc.","latestPrice":2.31,"timestamp":1731704400000,"preClose":2.39,"halted":0,"volume":70882,"hourTrading":{"tag":"盘后","latestPrice":2.31,"preClose":2.31,"latestTime":"19:42 EST","volume":183,"amount":429.9196,"timestamp":1731717731230},"delay":0,"floatShares":1405400,"shares":2486512,"eps":-0.43146,"marketStatus":"Closed","change":-0.08,"latestTime":"11-15 16:00:00 EST","open":2.42,"high":2.42,"low":2.27,"amount":165413.991946,"amplitude":0.062762,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.43146,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731920400000},"marketStatusCode":5,"adr":0,"listingDate":1679371200000,"exchange":"NASDAQ","adjPreClose":2.39,"preHourTrading":{"tag":"盘前","latestPrice":2.3801,"preClose":2.39,"latestTime":"08:30 EST","volume":1,"amount":2.3801,"timestamp":1731677459076},"postHourTrading":{"tag":"盘后","latestPrice":2.31,"preClose":2.31,"latestTime":"19:42 EST","volume":183,"amount":429.9196,"timestamp":1731717731230},"volumeRatio":0.843679},"requestUrl":"/m/hq/s/MGRX","defaultTab":"news","newsList":[{"id":"2479088072","title":"Mangoceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Bid Price Requirement","url":"https://stock-news.laohu8.com/highlight/detail?id=2479088072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479088072?lang=en_us&edition=fundamental","pubTime":"2024-10-31 20:00","pubTimestamp":1730376002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241031:nTUA3H8S8D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2477233230","title":"Mangoceuticals Shares Fall 3.3% on Plan to Evaluate Potential Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2477233230","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477233230?lang=en_us&edition=fundamental","pubTime":"2024-10-22 21:31","pubTimestamp":1729603875,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nFWN3LY0VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2477398503","title":"BUZZ-Mangoceuticals to evaluate potential strategic alternatives, shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2477398503","media":"Reuters","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477398503?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:45","pubTimestamp":1729601132,"startTime":"0","endTime":"0","summary":"** Shares of telehealth company Mangoceuticals   , also known as MangoRx, rise 2.1% to $3.94 premarket   ** Company says it has initiated a review process to evaluate potential strategic alternatives, including but not limited to potential mergers, acquisitions, divestitures and other transactions   ** MGRX has not established a timeline for completion of the review process   ** Earlier this week, Eli Lilly    sued three medical spas and online vendors, including MangoRx, for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss drug Zepbound   ** The lawsuit came after MangoRx launched its own brand called \"Trim\" — a compounded, oral dissolvable tirzepatide tablet   ** Up to last close, stock down 41.5% YTD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0823416689.USD","BK4128","LU0943347566.SGD","BK4007","LU0256863902.USD","IE0004445239.USD","LU1069344957.HKD","BK4585","LU0354030438.USD","LU0640476718.USD","MGRX","LU0882574139.USD","LU1023059063.AUD","GB00BDT5M118.USD","BK4534","LU1061106388.HKD","LU0256863811.USD","LU0122379950.USD","LLY","LU0079474960.USD","LU0106261372.USD","IE0009355771.USD","LU0058720904.USD","IE00B4R5TH58.HKD","IE00BK4W5L77.USD","LU0354030511.USD","LU0820561909.HKD","LU0417517546.SGD","IE00B1BXHZ80.USD","BK4581","BK4533","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU0385154629.USD","LU0061475181.USD","LU0096364046.USD","BK4516","IE00BK4W5M84.HKD","LU0672654240.SGD","LU1035775433.USD","IE0002141913.USD","LU0820561818.USD","BK4588","LU0109391861.USD","LU0238689110.USD","LU0708995401.HKD","LU1064131342.USD","IE00B2B36J28.USD"],"gpt_icon":1},{"id":"2477869339","title":"BRIEF-Mangorx Announces Formation Of Strategy And Alternatives Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2477869339","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477869339?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:45","pubTimestamp":1729601106,"startTime":"0","endTime":"0","summary":"Oct 22  - Mangoceuticals Inc   :   * MANGORX ANNOUNCES FORMATION OF STRATEGY AND ALTERNATIVES COMMITTEE   * MANGOCEUTICALS INC - BOARD INITIATES STRATEGIC REVIEW TO EVALUATE POTENTIAL STRATEGIC ALTERNATIVESSource text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2477336935","title":"Mangoceuticals board initiates process to evaluate strategic alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2477336935","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477336935?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:26","pubTimestamp":1729599970,"startTime":"0","endTime":"0","summary":"Mangoceuticals (MGRX) announced that its Board of Directors has initiated a process to evaluate potential strategic alternatives with the intent to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mangoceuticals-board-initiates-process-to-evaluate-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mangoceuticals-board-initiates-process-to-evaluate-strategic-alternatives?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2477338745","title":"Mangoceuticals Inc - Board Initiates Strategic Review to Evaluate Potential Strategic Alternatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2477338745","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477338745?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:00","pubTimestamp":1729598403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nTUA58B190:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2477338721","title":"Mangorx Announces Formation of Strategy and Alternatives Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2477338721","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477338721?lang=en_us&edition=fundamental","pubTime":"2024-10-22 20:00","pubTimestamp":1729598403,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241022:nTUA58B190:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2477438178","title":"Mangoceuticals 'Strongly Refutes' Eli Lilly's Claims About Copying Weight-Loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2477438178","media":"MT Newswires Live","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477438178?lang=en_us&edition=fundamental","pubTime":"2024-10-22 18:48","pubTimestamp":1729594103,"startTime":"0","endTime":"0","summary":"Mangoceuticals  said late Monday it \"strongly refutes\" Eli Lilly's  claims that the company \"improperly\" imitated its weight-loss Zepbound and Mounjaro medicines.\"MangoRx strongly refutes any and all claims made by Eli Lilly regarding the sale of compounded tirzepatide,\" the company added.Eli Lilly filed lawsuits against medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its weight-loss drug Zepbound.Eli Lilly did not immediately respond to MT Newswires' request for comment.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1057294990.SGD","BK4516","LU0238689110.USD","LU0097036916.USD","LU0079474960.USD","LU0708995401.HKD","IE00B2B36J28.USD","LU0385154629.USD","LU1023059063.AUD","LU0109391861.USD","LU0354030511.USD","LU0820561818.USD","BK4534","LU0823416689.USD","LU1093756168.USD","BK4581","LU0320765059.SGD","BK4533","LU0122379950.USD","IE00B4R5TH58.HKD","LLY","IE00BJLML261.HKD","LU0820561909.HKD","IE0009355771.USD","LU0006306889.USD","LU1069344957.HKD","LU1035775433.USD","BK4128","LU0943347566.SGD","IE00BK4W5M84.HKD","IE00BK4W5L77.USD","LU0456855351.SGD","LU0882574139.USD","LU0417517546.SGD","LU0096364046.USD","LU0198837287.USD","LU0203202063.USD","BK4585","BK4588","LU0640476718.USD","GB00BDT5M118.USD","LU0672654240.SGD","LU0354030438.USD","MGRX","LU0256863811.USD","IE00BJT1NW94.SGD","LU0114720955.EUR","LU0471298777.SGD","LU1061106388.HKD","LU0094547139.USD"],"gpt_icon":1},{"id":"2477817551","title":"BRIEF-Mangoceuticals Inc  Responds To Claims Made By Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2477817551","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477817551?lang=en_us&edition=fundamental","pubTime":"2024-10-22 05:42","pubTimestamp":1729546973,"startTime":"0","endTime":"0","summary":"Oct 21 (Reuters) - Eli Lilly and Co   :   * RESPONDS TO CLAIMS MADE BY ELI LILLY   * REFUTES ANY AND ALL CLAIMS MADE BY ELI LILLY REGARDING SALE OF COMPOUNDED TIRZEPATIDESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","LU0238689110.USD","LU0882574139.USD","BK4533","BK4516","LU0256863902.USD","LU1064131342.USD","LU0122379950.USD","LU0079474960.USD","LU0823416689.USD","BK4007","LU0820561818.USD","BK4585","LU0006306889.USD","LU0820561909.HKD","LU1061106388.HKD","LU0096364046.USD","LU0106261372.USD","LU0203202063.USD","LU0471298777.SGD","LU0943347566.SGD","IE00BJT1NW94.SGD","LU0882574055.USD","LU0114720955.EUR","LU0417517546.SGD","LU0198837287.USD","LU0320765059.SGD","MGRX","BK4128","BK4534","LU1035775433.USD","IE00BJLML261.HKD","LU0708995401.HKD","IE0002141913.USD","BK4581","IE00BJJMRZ35.SGD","LU0471298694.HKD","LU0456855351.SGD","LU0354030438.USD","LU0097036916.USD","LU0354030511.USD","LU0640476718.USD","IE00BFTCPJ56.SGD","IE00B1BXHZ80.USD","IE0004445239.USD","IE00BK4W5M84.HKD","LU1023059063.AUD","LU0256863811.USD","LU0466842654.USD","LLY"],"gpt_icon":0},{"id":"2477121448","title":"Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide","url":"https://stock-news.laohu8.com/highlight/detail?id=2477121448","media":"TIPRANKS","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477121448?lang=en_us&edition=fundamental","pubTime":"2024-10-22 05:15","pubTimestamp":1729545337,"startTime":"0","endTime":"0","summary":"“Mangoceuticals (MGRX) learned earlier this morning that Eli Lilly (LLY) has made certain public claims alleging, and has stated that it has filed ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mangoceuticals-refutes-claims-by-eli-lilly-regarding-sale-of-tirzepatide?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mangoceuticals-refutes-claims-by-eli-lilly-regarding-sale-of-tirzepatide?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LLY","LU0256863902.USD","LU0820561818.USD","LU1023059063.AUD","LU0823416689.USD","IE00B4R5TH58.HKD","LU0708995401.HKD","LU0256863811.USD","BK4588","IE00BFTCPJ56.SGD","LU1064131342.USD","LU0943347566.SGD","BK4585","LU1093756168.USD","LU0198837287.USD","LU0640476718.USD","IE0004445239.USD","LU0466842654.USD","LU0238689110.USD","LU0122379950.USD","LU0882574139.USD","BK4581","BK4128","LU0114720955.EUR","LU0320765059.SGD","BK4533","LU0061475181.USD","LU0456855351.SGD","LU0079474960.USD","LU1061106388.HKD","BK4516","LU0471298777.SGD","IE0002141913.USD","LU0820561909.HKD","IE00BK4W5L77.USD","LU0385154629.USD","BK4534","IE00B1BXHZ80.USD","IE00BK4W5M84.HKD","LU0058720904.USD","LU0882574055.USD","LU0289739699.SGD","LU0006306889.USD","LU0417517546.SGD","IE0009355771.USD","LU0471298694.HKD","LU1057294990.SGD","MGRX","IE00BJLML261.HKD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2477814150","title":"Mangoceuticals Inc:  Responds to Claims Made by Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2477814150","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477814150?lang=en_us&edition=fundamental","pubTime":"2024-10-22 05:10","pubTimestamp":1729545022,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241021:nFWN3LX0ZS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0354030438.USD","LU0289739699.SGD","LU0471298694.HKD","LU1064131342.USD","LU0943347566.SGD","BK4516","IE0004445239.USD","LU0882574139.USD","LU0820561909.HKD","LU1023059063.AUD","LU0097036916.USD","LU0471298777.SGD","LU0456855351.SGD","GB00BDT5M118.USD","LU0114720955.EUR","LLY","BK4128","BK4581","LU0354030511.USD","IE00BK4W5L77.USD","LU1069344957.HKD","LU0882574055.USD","LU1093756168.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0106261372.USD","LU0096364046.USD","LU0122379950.USD","LU0256863811.USD","LU0640476718.USD","IE00B1BXHZ80.USD","BK4534","MGRX","LU0203201768.USD","LU0256863902.USD","IE00BJLML261.HKD","LU0094547139.USD","LU0466842654.USD","IE00BK4W5M84.HKD","LU0320765059.SGD","LU0006306889.USD","LU0058720904.USD","BK4588","LU0238689110.USD","IE00BFTCPJ56.SGD","LU0198837287.USD","LU0061475181.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2477881427","title":"MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly","url":"https://stock-news.laohu8.com/highlight/detail?id=2477881427","media":"GlobeNewswire","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477881427?lang=en_us&edition=fundamental","pubTime":"2024-10-22 05:10","pubTimestamp":1729545000,"startTime":"0","endTime":"0","summary":"Dallas, Texas, Oct.  21, 2024  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling men’s health and wellness p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/21/2966542/0/en/MangoRx-Responds-to-and-Refutes-Recent-Claims-Made-by-Eli-Lilly.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640476718.USD","LU0097036916.USD","LU1069344957.HKD","LU0823416689.USD","IE0002141913.USD","LU0471298777.SGD","LU0203201768.USD","ED","BK4588","LU0079474960.USD","LU0203202063.USD","LU0256863811.USD","LU0058720904.USD","LU0289739699.SGD","LU1061106388.HKD","IE00B2B36J28.USD","LU0471298694.HKD","IE00BK4W5L77.USD","LU0708995401.HKD","IE00BK4W5M84.HKD","BK4007","IE00B4R5TH58.HKD","BK4128","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","BK4581","BK4208","LU0320765059.SGD","LU0943347566.SGD","LU2346227817.USD","IE00BJJMRZ35.SGD","LU0466842654.USD","LU0256863902.USD","LU0061475181.USD","LU0456855351.SGD","LU0385154629.USD","LU0820561818.USD","LU0672654240.SGD","WRD","LU0198837287.USD","IE00BJLML261.HKD","LU0882574139.USD","LU1057294990.SGD","IE0004445239.USD","LLY","BK4516","LU0006306889.USD","MGRX","IE0009355771.USD","LU0820561909.HKD"],"gpt_icon":1},{"id":"2477183164","title":"BUZZ-MangoRx falls as Lilly sues firm over sale of copycat weight-loss drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2477183164","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477183164?lang=en_us&edition=fundamental","pubTime":"2024-10-21 17:30","pubTimestamp":1729503013,"startTime":"0","endTime":"0","summary":"** Shares of telehealth company Mangoceuticals   , also known as MangoRx, fall 4% to $2.43 before the bell    ** Eli Lilly    sues three medical spas and online vendors, including MangoRx, for selling products claiming to contain tirzepatide, the main ingredient in its popular weight-loss drug Zepbound   ** Earlier this month, MangoRx launched its own brand called \"Trim\" - a compounded, oral dissolvable tirzepatide tablet    ** Lilly said MangoRx was selling an oral version despite the lack of any study showing that formulation to be safe and effective    ** MangoRx also sells \"Slim\", its oral compounded formulation of semaglutide, the active ingredient in Novo Nordisk's    Wegovy    ** MangoRx did not immediately respond to a request for comment    ** As of last close, MGRX down nearly 42% YTD  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0943347566.SGD","IE0002141913.USD","LU0320765059.SGD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0466842654.USD","LU0708995401.HKD","LU0882574139.USD","IE00BFTCPJ56.SGD","LU0820561909.HKD","IE0009355771.USD","LU0820561818.USD","LU0882574055.USD","LU1057294990.SGD","LU0672654240.SGD","LU0471298694.HKD","IE00B1BXHZ80.USD","LU0203201768.USD","LU0689472784.USD","BK4128","BK4581","IE00BK4W5M84.HKD","LU0097036916.USD","LU0640476718.USD","LU1061106388.HKD","LU1064131342.USD","LU0823416689.USD","IE00BJJMRZ35.SGD","IE00BJLML261.HKD","LU0385154629.USD","LU0058720904.USD","LU0198837287.USD","LU0203202063.USD","IE00BK4W5L77.USD","IE00B4R5TH58.HKD","LU1069344957.HKD","BK4007","LU0096364046.USD","LU0106261372.USD","BK4588","IE00B2B36J28.USD","MGRX","IE0004445239.USD","LU0061475181.USD","LU0256863811.USD","LU0289739699.SGD","LLY","LU0006306889.USD","LU0122379950.USD","BK4516"],"gpt_icon":1},{"id":"2477655831","title":"Mangoceuticals Shares Down 4.3% Premarket After Eli Lilly Sues Online Vendors, Medical Spa Over Copycat Weight-Loss Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2477655831","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477655831?lang=en_us&edition=fundamental","pubTime":"2024-10-21 17:09","pubTimestamp":1729501772,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241021:nFWN3LV056:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2476232666","title":"Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2476232666","media":"Newsfile","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476232666?lang=en_us&edition=fundamental","pubTime":"2024-10-18 20:45","pubTimestamp":1729255500,"startTime":"0","endTime":"0","summary":"Dallas, Texas-- - Mangoceuticals, Inc. , a company focused on developing, marketing, and selling men’s health and wellness products via a secure telemedicine platform,, is pleased to announce it will be presenting at the Centurion One Capital 2nd Annual Bahamas Summit, which will be taking place at the exclusive Rosewood Baha Mar Hotel from Tuesday, October 22nd to Wednesday, October 23rd, 2024, in Nassau, Bahamas.Jacob Cohen, Founder and CEO, is scheduled to present on Wednesday, October 23rd at 11:10 EDT. Jacob will also be fielding investor questions during the summit.The Centurion One Capital 2nd Annual Bahamas Summit will feature public and private companies across various industries that will be given the opportunity to present to some of the most prominent venture capital, family office, private equity firms, high net worth individuals and institutional investors in the growth space attending from Canada, the United States, and abroad. For registration details, please click here","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/mangoceuticals-inc-announces-participation-centurion-124500745.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mangoceuticals-inc-announces-participation-centurion-124500745.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SMMF","ED","LU2346227817.USD","MGRX","BK4585","BK4208","BK4211","BK4588","BK4128","LU0170899867.USD"],"gpt_icon":0},{"id":"2474902307","title":"Mangoceuticals announces 1-for-15 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2474902307","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474902307?lang=en_us&edition=fundamental","pubTime":"2024-10-12 05:32","pubTimestamp":1728682336,"startTime":"0","endTime":"0","summary":"Mangoceuticals, Inc.  said on Friday that it will conduct a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-15. The Reverse Stock Split will become effective on October 16, 2024, at 12:01 a.m. Eastern Time, with shares expected to begin trading on the Nasdaq Capital Market.  The Reverse Stock Split is part of the company’s plan to regain compliance with the minimum bid price requirement of $1 per share required to maintain continued listing. The Reverse Stock Split will reduce the number of shares of the Company's outstanding common stock from approximately 35.5M shares to approximately 2.4M shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4158032-mangoceuticals-announces-1-for-15-reverse-stock-split","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["MGRX","BK4128"],"gpt_icon":0},{"id":"2474028930","title":"Mangoceuticals, Inc. Announces 1-for 15 Reverse Stock Split as Part of Nasdaq Compliance Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2474028930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474028930?lang=en_us&edition=fundamental","pubTime":"2024-10-12 05:15","pubTimestamp":1728681300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nTUA2Q5LFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4128","MGRX"],"gpt_icon":0},{"id":"2474157028","title":"MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN","url":"https://stock-news.laohu8.com/highlight/detail?id=2474157028","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474157028?lang=en_us&edition=fundamental","pubTime":"2024-10-12 05:15","pubTimestamp":1728681300,"startTime":"0","endTime":"0","summary":"DALLAS, TX, Oct.  11, 2024  (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/11/2962215/0/en/MANGOCEUTICALS-INC-ANNOUNCES-1-FOR-15-REVERSE-STOCK-SPLIT-AS-PART-OF-NASDAQ-COMPLIANCE-PLAN.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INC","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","NDAQ","BK4128","BK4208","LU2346227817.USD","ED",".IXIC","BK4024","LU0170899867.USD","MGRX","BK4585","BK4588","IE00B3QW5Z07.USD","FOR","LU2210149790.SGD","LU2210150020.SGD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2472697961","title":"Mangoceuticals Inc - Trim Available for Purchase at $399 per Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2472697961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472697961?lang=en_us&edition=fundamental","pubTime":"2024-10-03 20:30","pubTimestamp":1727958601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241003:nTUA4RR6GY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4581","IE00BJT1NW94.SGD","LU0417517546.SGD","IE0009355771.USD","LU0708995401.HKD","IE00BK4W5L77.USD","LU1035775433.USD","LU0320765059.SGD","LU1064131342.USD","LLY","LU0471298694.HKD","LU0096364046.USD","BK4534","BK4007","LU0354030438.USD","LU0689472784.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0061475181.USD","LU0640476718.USD","LU1093756325.SGD","LU0823416689.USD","IE00BK4W5M84.HKD","LU0094547139.USD","GB00BDT5M118.USD","IE00BFTCPJ56.SGD","LU0238689110.USD","LU0256863811.USD","IE00BJLML261.HKD","LU1093756168.USD","LU0106261372.USD","MGRX","LU0256863902.USD","LU1023059063.AUD","LU1267930730.SGD","LU0385154629.USD","BK4516","BK4128","LU0354030511.USD","LU0289739699.SGD","BK4585","IE0002141913.USD","LU0058720904.USD","LU0079474960.USD","LU0672654240.SGD","LU0114720955.EUR","BK4533","LU0198837287.USD","LU1069344957.HKD"],"gpt_icon":0},{"id":"2472697608","title":"Mangorx Introduces Oral Tirzepatide Glp-1 Receptor Agonist for Advanced Weight Loss Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2472697608","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472697608?lang=en_us&edition=fundamental","pubTime":"2024-10-03 20:30","pubTimestamp":1727958601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241003:nTUA4RR6GY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BK4W5M84.HKD","LU1069344957.HKD","IE00BK4W5L77.USD","LU0256863902.USD","LU0289739699.SGD","IE0002141913.USD","GB00BDT5M118.USD","LU0823416689.USD","LU0471298694.HKD","IE00B2B36J28.USD","BK4585","IE00B4R5TH58.HKD","LU0058720904.USD","LU0354030438.USD","BK4128","BK4581","LU0106261372.USD","LU0708995401.HKD","LU0061475181.USD","IE00BJLML261.HKD","LU1023059063.AUD","LU1035775433.USD","LU0354030511.USD","LU1093756325.SGD","LU1064131342.USD","BK4516","MGRX","LLY","LU0079474960.USD","LU0094547139.USD","LU1267930730.SGD","BK4534","LU0689472784.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0640476718.USD","LU0096364046.USD","LU0320765059.SGD","LU0114720955.EUR","LU0198837287.USD","BK4007","BK4533","LU0672654240.SGD","LU0385154629.USD","LU1093756168.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU0256863811.USD","LU0417517546.SGD","LU0238689110.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mangorx.com","stockEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":-0.0978},{"period":"3month","weight":-0.5135},{"period":"6month","weight":-0.3389},{"period":"1year","weight":-0.6345},{"period":"ytd","weight":-0.4246}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.","exchange":"NASDAQ","name":"Mangoceuticals, Inc.","nameEN":"Mangoceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mangoceuticals, Inc.(MGRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mangoceuticals, Inc.,MGRX,Mangoceuticals, Inc.股票,Mangoceuticals, Inc.股票老虎,Mangoceuticals, Inc.股票老虎国际,Mangoceuticals, Inc.行情,Mangoceuticals, Inc.股票行情,Mangoceuticals, Inc.股价,Mangoceuticals, Inc.股市,Mangoceuticals, Inc.股票价格,Mangoceuticals, Inc.股票交易,Mangoceuticals, Inc.股票购买,Mangoceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mangoceuticals, Inc.(MGRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mangoceuticals, Inc.(MGRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}